tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Technical Analysis

7,852 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is -0.98, suggesting Crispr Therapeutics AG is a Buy.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 57.13, while Crispr Therapeutics AG’s (CRSP) share price is $53.115, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 58.51, while Crispr Therapeutics AG’s (CRSP) share price is $53.115, making it a Sell.

Crispr Therapeutics AG (CRSP) Pivot Points

Jul 03, 2024, 10:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
50.59
51.95
52.95
54.31
55.31
56.67
57.67
Fibonacci
51.95
52.85
53.41
54.31
55.21
55.77
56.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Jul 03, 2024, 10:19 AM
Period
Simple
Exponential
MA5
54.62Sell
54.53Sell
MA10
56.34Sell
56.02Sell
MA20
58.85Sell
57.13Sell
MA50
56.55Sell
58.51Sell
MA100
64.64Sell
60.36Sell
MA200
60.55Sell
58.46Sell
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 56.02, while Crispr Therapeutics AG’s (CRSP) share price is $53.115, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 60.36, while Crispr Therapeutics AG’s (CRSP) share price is $53.115, making it a Sell.
Crispr Therapeutics AG’s (CRSP) stock price is $53.115 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 56.55, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $53.115 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 64.64, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $53.115 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 60.55, creating a Sell signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Jul 03, 2024, 10:19 AM
Name
Value
Implied Action
RSI (14)
37.66
Neutral
STOCH (9,6)
7.30
Buy
STOCHRSI (14)
4.32
Buy
MACD (12,26)
-0.98
Buy
ADX (14)
18.62
Buy
Williams %R
-96.09
Buy
CCI (14)
-139.74
Buy
ATR (14)
2.64
-
Ultimate Oscillator
37.60
Neutral
ROC
-14.75
Sell
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 37.66, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 18.62, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is -139.74, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is -14.75, creating a Sell signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Sell.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 37.66, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is -0.98, which suggests CRSP is a Buy.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 54.62, which suggests CRSP is a Sell.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 58.85, which suggests CRSP is a Sell.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 56.55, which suggests CRSP is a Sell.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 60.55, which suggests CRSP is a Sell.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -96.09, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is -139.74, which suggests CRSP is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis